FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2258144468> ?p ?o ?g. }

• W2258144468 endingPage "1346" @default.
• W2258144468 startingPage "1336" @default.
• W2258144468 abstract "Gray matter degeneration contributes to progressive disability in multiple sclerosis (MS) and can occur out of proportion to measures of white matter disease. Although white matter pathology, including demyelination and axon injury, can lead to secondary gray matter changes, we hypothesized that neurons can undergo direct excitatory injury within the gray matter independent of these. We tested this using a model of experimental autoimmune encephalomyelitis (EAE) with hippocampal degeneration in C57BL/6 mice, in which immunofluorescent staining showed a 28% loss of PSD95-positive excitatory postsynaptic puncta in hippocampal area CA1 compared with sham-immunized controls, despite preservation of myelin and VGLUT1-positive excitatory axon terminals. Loss of postsynaptic structures was accompanied by appearance of PSD95-positive debris that colocalized with the processes of activated microglia at 25 d after immunization, and clearance of debris was followed by persistently reduced synaptic density at 55 d. In vitro, addition of activated BV2 microglial cells to hippocampal cultures increased neuronal vulnerability to excitotoxic dendritic damage following a burst of synaptic activity in a manner dependent on platelet-activating factor receptor (PAFR) signaling. In vivo treatment with PAFR antagonist BN52021 prevented PSD95-positive synapse loss in hippocampi of mice with EAE but did not affect development of EAE or local microglial activation. These results demonstrate that postsynaptic structures can be a primary target of injury within the gray matter in autoimmune neuroinflammatory disease, and suggest that this may occur via PAFR-mediated modulation of activity-dependent synaptic physiology downstream of microglial activation.Unraveling gray matter degeneration is critical for developing treatments for progressive disability and cognitive impairment in multiple sclerosis (MS). In a mouse model of MS, we show that neurons can undergo injury at their synaptic connections within the gray matter, independent of the white matter pathology, demyelination, and axon injury that have been the focus of most current and emerging treatments. Damage to excitatory synapses in the hippocampus occurs in association with activated microglia, which can promote excitotoxic injury via activation of receptors for platelet-activating factor, a proinflammatory signaling molecule elevated in the brain in MS. Platelet-activating factor receptor blockade protected synapses in the mouse model, identifying a potential target for neuroprotective treatments in MS." @default.
• W2258144468 created "2016-06-24" @default.
• W2258144468 creator A5012563424 @default.
• W2258144468 creator A5027264967 @default.
• W2258144468 creator A5033967453 @default.
• W2258144468 creator A5046708994 @default.
• W2258144468 date "2016-01-27" @default.
• W2258144468 modified "2023-10-14" @default.
• W2258144468 title "Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis" @default.
• W2258144468 cites W1482855280 @default.
• W2258144468 cites W1513212892 @default.
• W2258144468 cites W1954660491 @default.
• W2258144468 cites W1994551577 @default.
• W2258144468 cites W1997390910 @default.
• W2258144468 cites W2004842526 @default.
• W2258144468 cites W2006178657 @default.
• W2258144468 cites W2006257281 @default.
• W2258144468 cites W2006359010 @default.
• W2258144468 cites W2007585025 @default.
• W2258144468 cites W2009651498 @default.
• W2258144468 cites W2013370381 @default.
• W2258144468 cites W2013908566 @default.
• W2258144468 cites W2024309355 @default.
• W2258144468 cites W2025921501 @default.
• W2258144468 cites W2027467386 @default.
• W2258144468 cites W2048403952 @default.
• W2258144468 cites W2049317842 @default.
• W2258144468 cites W2055839901 @default.
• W2258144468 cites W2059830045 @default.
• W2258144468 cites W2060264243 @default.
• W2258144468 cites W2060916221 @default.
• W2258144468 cites W2071151220 @default.
• W2258144468 cites W2079723480 @default.
• W2258144468 cites W2086613181 @default.
• W2258144468 cites W2090777067 @default.
• W2258144468 cites W2101000495 @default.
• W2258144468 cites W2107066201 @default.
• W2258144468 cites W2110553599 @default.
• W2258144468 cites W2123519848 @default.
• W2258144468 cites W2130974415 @default.
• W2258144468 cites W2170962446 @default.
• W2258144468 doi "https://doi.org/10.1523/jneurosci.1171-15.2016" @default.
• W2258144468 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4728729" @default.
• W2258144468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26818520" @default.
• W2258144468 hasPublicationYear "2016" @default.
• W2258144468 type Work @default.
• W2258144468 sameAs 2258144468 @default.
• W2258144468 citedByCount "37" @default.
• W2258144468 countsByYear W22581444682016 @default.
• W2258144468 countsByYear W22581444682017 @default.
• W2258144468 countsByYear W22581444682018 @default.
• W2258144468 countsByYear W22581444682019 @default.
• W2258144468 countsByYear W22581444682020 @default.
• W2258144468 countsByYear W22581444682021 @default.
• W2258144468 countsByYear W22581444682022 @default.
• W2258144468 countsByYear W22581444682023 @default.
• W2258144468 crossrefType "journal-article" @default.
• W2258144468 hasAuthorship W2258144468A5012563424 @default.
• W2258144468 hasAuthorship W2258144468A5027264967 @default.
• W2258144468 hasAuthorship W2258144468A5033967453 @default.
• W2258144468 hasAuthorship W2258144468A5046708994 @default.
• W2258144468 hasBestOaLocation W22581444681 @default.
• W2258144468 hasConcept C112592302 @default.
• W2258144468 hasConcept C126838900 @default.
• W2258144468 hasConcept C143409427 @default.
• W2258144468 hasConcept C148762608 @default.
• W2258144468 hasConcept C169760540 @default.
• W2258144468 hasConcept C170493617 @default.
• W2258144468 hasConcept C17077164 @default.
• W2258144468 hasConcept C197341189 @default.
• W2258144468 hasConcept C2778486448 @default.
• W2258144468 hasConcept C2779530196 @default.
• W2258144468 hasConcept C2781192897 @default.
• W2258144468 hasConcept C529278444 @default.
• W2258144468 hasConcept C55493867 @default.
• W2258144468 hasConcept C71924100 @default.
• W2258144468 hasConcept C86803240 @default.
• W2258144468 hasConceptScore W2258144468C112592302 @default.
• W2258144468 hasConceptScore W2258144468C126838900 @default.
• W2258144468 hasConceptScore W2258144468C143409427 @default.
• W2258144468 hasConceptScore W2258144468C148762608 @default.
• W2258144468 hasConceptScore W2258144468C169760540 @default.
• W2258144468 hasConceptScore W2258144468C170493617 @default.
• W2258144468 hasConceptScore W2258144468C17077164 @default.
• W2258144468 hasConceptScore W2258144468C197341189 @default.
• W2258144468 hasConceptScore W2258144468C2778486448 @default.
• W2258144468 hasConceptScore W2258144468C2779530196 @default.
• W2258144468 hasConceptScore W2258144468C2781192897 @default.
• W2258144468 hasConceptScore W2258144468C529278444 @default.
• W2258144468 hasConceptScore W2258144468C55493867 @default.
• W2258144468 hasConceptScore W2258144468C71924100 @default.
• W2258144468 hasConceptScore W2258144468C86803240 @default.
• W2258144468 hasIssue "4" @default.
• W2258144468 hasLocation W22581444681 @default.
• W2258144468 hasLocation W22581444682 @default.
• W2258144468 hasLocation W22581444683 @default.
• W2258144468 hasLocation W22581444684 @default.
• W2258144468 hasOpenAccess W2258144468 @default.

• next